Benralizumab and mepolizumab treatment outcomes in two severe asthma clinics. Langton D, Politis J, Collyer T, Khung SW, et al. Respirology 2023 Aug 28. doi: 10.1111/resp.14578.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Langton D, Politis J, Collyer T, Khung SW, et al. Benralizumab and mepolizumab treatment outcomes in two severe asthma clinics. Respirology 2023 Aug 28. doi: 10.1111/resp.14578.
PMID: 37638723